|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Collaboration revenue | |||||
| Other operating income | |||||
| Total operating income | |||||
| Cost of sales | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Loss from investment in a joint venture | |||||
| Total operating expenses | |||||
| Operating profit/(loss) | |||||
| Financial income | |||||
| Financial expense | |||||
| Exchange gains/(losses) | |||||
| Profit/(Loss) for the year before taxes | |||||
| Income tax benefit | |||||
| Profit/(Loss) for the year | |||||
| Profit/(Loss) for the year attributable to: | |||||
| Owners of the parent | |||||
| Weighted average number of shares used for basic profit/(loss) per share (in shares) | |||||
| Basic profit/(loss) per share (in USD per share) | |||||
| Weighted average number of shares used for diluted profit/(loss) per share (in shares) | |||||
| Diluted profit/(loss) per share (in USD per share) | |||||
Loading...
